Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
| Status: | Completed |
|---|---|
| Conditions: | Allergy |
| Therapuetic Areas: | Otolaryngology |
| Healthy: | No |
| Age Range: | 12 - Any |
| Updated: | 1/20/2017 |
| Start Date: | August 2005 |
| End Date: | October 2005 |
A Randomized, Single-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100 mcg for 2 Weeks in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis
Allergic rhinitis is an inflammatory disorder of the upper airway that occurs following
allergen exposure. The focus of this study, seasonal allergic rhinitis (SAR), is one type of
allergic rhinitis that is triggered by the pollen from trees, grasses, and weeds. Commonly
referred to as (hay fever), it is characterized by sneezing, nasal congestion and pruritus,
rhinorrhea, and pruritic, watery, red eyes. The primary objective of this study is to
compare the efficacy and safety of GW685698X 100mcg once daily (QD) aqueous nasal spray with
vehicle placebo nasal spray in adult and adolescent subjects (12 years of age and older)
with seasonal allergic rhinitis (SAR) caused by ragweed pollen.
allergen exposure. The focus of this study, seasonal allergic rhinitis (SAR), is one type of
allergic rhinitis that is triggered by the pollen from trees, grasses, and weeds. Commonly
referred to as (hay fever), it is characterized by sneezing, nasal congestion and pruritus,
rhinorrhea, and pruritic, watery, red eyes. The primary objective of this study is to
compare the efficacy and safety of GW685698X 100mcg once daily (QD) aqueous nasal spray with
vehicle placebo nasal spray in adult and adolescent subjects (12 years of age and older)
with seasonal allergic rhinitis (SAR) caused by ragweed pollen.
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to
Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X
Aqueous Nasal Spray 100mcg for 2 Weeks in Adult and Adolescent Subjects (12 years of age and
older) with Seasonal Allergic Rhinitis (SAR)
Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X
Aqueous Nasal Spray 100mcg for 2 Weeks in Adult and Adolescent Subjects (12 years of age and
older) with Seasonal Allergic Rhinitis (SAR)
Inclusion criteria:
- Must be outpatients.
- Diagnosis of SAR.
- Literate in English or native language.
Exclusion criteria:
- Have a significant concomitant medical condition.
- Use corticosteroids or other allergy medications during the study.
- Use tobacco products.
We found this trial at
17
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials